Aspirin for primary prevention of vascular disease in people with diabetes

BMJ. 2009 Nov 6:339:b4596. doi: 10.1136/bmj.b4596.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Cardiovascular Agents / administration & dosage*
  • Cardiovascular Agents / adverse effects
  • Diabetic Angiopathies / prevention & control*
  • Humans
  • Primary Prevention

Substances

  • Cardiovascular Agents
  • Aspirin